Cardiac fibrosis in diabetic rats: Regulation and mechanism of activation of the PPARγ signal pathway

Chinese Journal of Physiology

Volumn 53, Issue 4, 2010, Pages 262-267

  Zhao, Shu Mei ^a   Li, Hong Wei ^a   Guo, Chun Yan ^a   Shen, Lu Hua ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II type 1 receptor (AT1 R); Cardiac fibrosis; Diabetes; PPAR signal pathway

Indexed keywords

ANGIOTENSIN 2 RECEPTOR; COLLAGEN TYPE 3; GLUCOSE; HYDROXYPROLINE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; ECHOCARDIOGRAPHY; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

EID: 78149449329     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: 10.4077/CJP.2010.AMK076     Document Type: Article

References (13)

1. Bastos, E.L., Fagundes, D.J., Taha, M.O., Novo, N.F., Juliano, Y., Simões, Mde, J. and Silvado, R.A. The role of bovine preserved peritoneum in rats ventral hernia: a histological evaluation. Acta Cir. Bras. 21: 328-331, 2006.
2. Jin, D., Takai, S., Sugiyama, T., Hayashi, T., Fukumoto, M., Oku, H., Kitaura, Y., Ikeda, T. and Miyazaki, M. Long-term angiotensin II blockade may improve not only hyperglycemia but also ageassociated cardiac fibrosis. J Pharmacol. Sci. 109: 275-284, 2009.
3. Marx, N., Walcher, D., Ivanova, N., Rautzenberg, K., Jung, A., Friedl, R., Hombach, V., de, Caterina, R., Basta, G., Wautier, M.P. and Wautiers, J.L. Thiazolidinediones reduce endothelial expression of receptor for advanced glycation end products. Diabetes 53: 2662-2668, 2004.
4. McCalmon, S.A., Desjardins, D.M., Ahmad, S., Davidoff, K.S., Snyder, C.M., Sato, K., Ohashi, K., Kielbasa, O.M., Mathew, M., Ewen, E.P., Walsh, K., Gavras, H. and Naya, F.J. Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene xirp2. Circ. Res. Jan 21: [Epub ahead of print], 2010.
5. Min, Q., Bai, Y.T., Jia, G., Wu, J. and Xiang, J.Z. High glucose enhances angiotensin-II-mediated peroxisome proliferationactivated receptor-γ inactivation in human coronary artery endothelial cells. Exp. Mol. Pathol. 88: 133-137, 2010.
6. Negro, R., Dazzi, D., Hassan, H. and Pezzarossa, A. Pioglitazone reduces blood pressure in non-dipping diabetic patients. Minerva. Endocrinol. 29: 11-17, 2004.
7. Panchapakesan, U., Sumula, S., Pollock, C.A. and Chen, X. PPARγ agonist exert antifibrotic effects in renal tubular cells exposed to high glucose. Am. J. Physiol. Renal. Physiol. 289: F1153-F1158, 2005.
8. Ren, L., Li, Y., Li, Y., Tang, R., Hu, D., Sheng, Z. and Liu, N. The inhibitory effects of rosiglitazone on cardiac hypertrophy through modulating the renin-angiotensin system in diet-induced hypercholesterolemic rats. Cell Biochem. Funct. 28: 58-65, 2010.
9. Takano, H., Hasegawa, H., Nagai, T. and Komuro, I. Implication of cardiac remodeling in heart failure: mechanisms and therapeutic strategies. Intern. Med. 42: 465-469, 2003.
10. van, Deutekom, A.W., Niessen, H.W., Schalkwijk, C.G., Heine, R.J. and Simsek, S. Increased Nepsilon-(carboxymethyl)-lysine levels in cerebral blood vessels of diabetic patients and in a (streptozotocin-treated) rat model of diabetes mellitus. Eur. J. Endocrinol. 158: 655-660, 2008.
11. van, Westerloo, D.J., Florquin, S., de, Boer, A.M., Daalhuisen, J., de, Vos, A.F., Bruno, M.J. and van, der, Poll, T. Therapeutic effects of troglitazone in experimental chronic pancreatitis in mice. Am. J. Pathol. 166: 721-728, 2005.
12. Yue, T.L., Chen, J., Bao, W.K., Narayanan, P.K., Bril, A., Jiang, W., Lysko, P.G., Gu, J.L., Boyce, R., Zimmerman, D.M., Hart, T.K., Buckingham, R.E. and Ohlstein, E.H. In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferatoractivated receptor-γ agonist rosiglitazone. Circulation 104: 2588-2594, 2001.
13. Zhao, S.M., Shen, L.H., Li, H.W., Wang, L., Chen, H., Wang, Y.L. and Guo, C.Y. Down-regulation of the expression of angiotensin II type 1 receptor in neonatal rat cardiac fibroblast by activation of PPARγ signal pathway. Chinese J. Physiol. 51: 357-362, 2008.